CZS-241 is an orally active, selective Polo-like Kinase (PLK) 4 inhibitor with an IC 50 of 2.6 nM that also inhibits TRKA at an IC 50 of 2.74 µM. It induces apoptosis and causes cell cycle arrest at the S/G2 phase, demonstrating potent antiproliferative effectiveness against leukemia cell lines while maintaining safety towards normal cell lines.
Molecular Weight:
551.98
Formula:
C26H24ClF2N9O
Target:
Trk receptor|||PLK|||Apoptosis|||Others
T73449
* VAT and and shipping costs not included. Errors and price changes excepted
